These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8578807)

  • 1. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia.
    Fulop M; Manchee R; Titball R
    Vaccine; 1995 Sep; 13(13):1220-5. PubMed ID: 8578807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence.
    Fulop M; Manchee R; Titball R
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):245-7. PubMed ID: 8861037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
    Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
    Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia.
    Sjöstedt A; Sandström G; Tärnvik A
    Res Microbiol; 1990; 141(7-8):887-91. PubMed ID: 2101478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a cloned Francisella tularensis outer membrane protein gene and expression in attenuated Salmonella typhimurium.
    Leslie DL; Cox J; Lee M; Titball RW
    FEMS Microbiol Lett; 1993 Aug; 111(2-3):331-5. PubMed ID: 8405941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium.
    Sjöstedt A; Sandström G; Tärnvik A
    Infect Immun; 1992 Jul; 60(7):2855-62. PubMed ID: 1612751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.
    Chiavolini D; Weir S; Murphy JR; Wetzler LM
    Clin Vaccine Immunol; 2008 Sep; 15(9):1322-9. PubMed ID: 18614668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M; Mastroeni P; Green M; Titball RW
    Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
    Dreisbach VC; Cowley S; Elkins KL
    Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
    Cole LE; Yang Y; Elkins KL; Fernandez ET; Qureshi N; Shlomchik MJ; Herzenberg LA; Herzenberg LA; Vogel SN
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4343-8. PubMed ID: 19251656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
    Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
    Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
    Savitt AG; Mena-Taboada P; Monsalve G; Benach JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):414-22. PubMed ID: 19176692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice.
    Oh H; Kim CY; Kim CH; Hur GH; Park JH
    J Microbiol Biotechnol; 2016 Sep; 26(9):1613-9. PubMed ID: 27238938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.